QuantaMatrix, a Korean in-vitro diagnostics company, will release its Alzheimer's early detection test, AlzPlus, as a non-reimbursable service starting next Monday. The launch follows a notification issued by the Ministry of Health and Welfare after an amendment to the provisional approval of the Ne